Figure 5.
Cell viability and inhibition of iNOS and COX-2 in BV2 cells. (a–d) Cell viability of BV2 cells. The determination of cell viability of BV2 cells is carried out by CCK-8 assay after treated with control or (a) Echinacoside (E), (b) Verbascoside (V), (c) Isoacteoside (I), or (d) 2′-acetylacteoside (2A) (37.5, 75, 150, or 300 μM) for 24 h. No significant differences are found among groups. (e–g) BV2 cells are pretreated with (e) I or 2A (150 or 300 μM), (f) E or V (150 or 300 μM), and (g) E or 2A (75, 150 or 300 μM) or the combinations for 2 h, vehical as the control. Then exposure to LPS (1 μg/ml) for 18 h, then iNOS and COX-2 accumulation of cytoplasm are measured by western blot. β-actin is used as loading control. All results are repeated at least three independent experiments with the same tendency.